Literature DB >> 25485899

Obesity superimposed on aging magnifies inflammation and delays the resolving response after myocardial infarction.

Elizabeth F Lopez1, Janusz H Kabarowski2, Kevin A Ingle3, Vasundhara Kain3, Stephen Barnes4, David K Crossman5, Merry L Lindsey6, Ganesh V Halade7.   

Abstract

Polyunsaturated fatty acid (PUFA) intake has increased over the last 100 yr, contributing to the current obesogenic environment. Obesity and aging are prominent risk factors for myocardial infarction (MI). How obesity interacts with aging to alter the post-MI response, however, is unclear. We tested the hypothesis that obesity in aging mice would impair the resolution of post-MI inflammation. PUFA diet (PUFA aging group) feeding to 12-mo-old C57BL/6J mice for 5 mo showed higher fat mass compared with standard lab chow (LC)-fed young (LC young group; 3-5 mo old) or aging alone control mice (LC aging group). LC young, LC aging, and PUFA aging mice were subjected to coronary artery ligation to induce MI. Despite similar infarct areas post-MI, plasma proteomic profiling revealed higher VCAM-1 in the PUFA aging group compared with LC young and LC aging groups, leading to increased neutrophil infiltration in the PUFA aging group (P<0.05). Macrophage inflammatory protein-1γ and CD40 were also increased at day 1, and myeloperoxidase remained elevated at day 5, an observation consistent with delayed wound healing in the PUFA aging group. Lipidomic analysis showed higher levels of arachidonic acid and 12(S)-hydroxyeicosatetraenoic acid at day 1 post-MI in the PUFA aging group compared with the LC aging group (all P<0.05), thereby mediating neutrophil extravasation in the PUFA aging group. The inflammation-resolving enzymes 5-lipoxygenase, cyclooxygenase-2, and heme oxyegnase-1 were altered to delay wound healing post-MI in the PUFA aging group compared with LC young and LC aging groups. PUFA aging magnifies the post-MI inflammatory response and impairs the healing response by stimulating prolonged neutrophil trafficking and proinflammatory lipid mediators.

Entities:  

Keywords:  inflammation; lipid mediators; lipidomics; neutrophils; polyunsaturated fatty acids; proteomics

Mesh:

Substances:

Year:  2014        PMID: 25485899      PMCID: PMC4329482          DOI: 10.1152/ajpheart.00604.2014

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  45 in total

Review 1.  The aging heart and post-infarction left ventricular remodeling.

Authors:  Henry Shih; Brian Lee; Randall J Lee; Andrew J Boyle
Journal:  J Am Coll Cardiol       Date:  2011-01-04       Impact factor: 24.094

Review 2.  Dietary fat and heart failure: moving from lipotoxicity to lipoprotection.

Authors:  William C Stanley; Erinne R Dabkowski; Rogerio F Ribeiro; Kelly A O'Connell
Journal:  Circ Res       Date:  2012-03-02       Impact factor: 17.367

3.  Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice.

Authors:  S F Yet; R Tian; M D Layne; Z Y Wang; K Maemura; M Solovyeva; B Ith; L G Melo; L Zhang; J S Ingwall; V J Dzau; M E Lee; M A Perrella
Journal:  Circ Res       Date:  2001-07-20       Impact factor: 17.367

4.  High fat diet-induced animal model of age-associated obesity and osteoporosis.

Authors:  Ganesh V Halade; Md M Rahman; Paul J Williams; Gabriel Fernandes
Journal:  J Nutr Biochem       Date:  2010-02-10       Impact factor: 6.048

5.  Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century.

Authors:  Tanya L Blasbalg; Joseph R Hibbeln; Christopher E Ramsden; Sharon F Majchrzak; Robert R Rawlings
Journal:  Am J Clin Nutr       Date:  2011-03-02       Impact factor: 7.045

6.  Impaired resolution of inflammation in human chronic heart failure.

Authors:  Marta Reina-Couto; Jorge Carvalho; Maria João Valente; Luís Vale; Joana Afonso; Félix Carvalho; Paulo Bettencourt; Teresa Sousa; António Albino-Teixeira
Journal:  Eur J Clin Invest       Date:  2014-04-22       Impact factor: 4.686

7.  High intake of saturated fat, but not polyunsaturated fat, improves survival in heart failure despite persistent mitochondrial defects.

Authors:  Tatiana F Galvao; Bethany H Brown; Peter A Hecker; Kelly A O'Connell; Karen M O'Shea; Hani N Sabbah; Sharad Rastogi; Caroline Daneault; Christine Des Rosiers; William C Stanley
Journal:  Cardiovasc Res       Date:  2011-09-29       Impact factor: 10.787

8.  Reduced BDNF attenuates inflammation and angiogenesis to improve survival and cardiac function following myocardial infarction in mice.

Authors:  Ganesh V Halade; Yonggang Ma; Trevi A Ramirez; Jianhua Zhang; Qiuxia Dai; Julie G Hensler; Elizabeth F Lopez; Omid Ghasemi; Yu-Fang Jin; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-18       Impact factor: 4.733

Review 9.  MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy.

Authors:  Ying Xia; Nikolaos G Frangogiannis
Journal:  Inflamm Allergy Drug Targets       Date:  2007-06

10.  Health implications of high dietary omega-6 polyunsaturated Fatty acids.

Authors:  E Patterson; R Wall; G F Fitzgerald; R P Ross; C Stanton
Journal:  J Nutr Metab       Date:  2012-04-05
View more
  41 in total

Review 1.  Matrix metalloproteinase-12 as an endogenous resolution promoting factor following myocardial infarction.

Authors:  Alan J Mouton; Osvaldo J Rivera Gonzalez; Amanda R Kaminski; Edwin T Moore; Merry L Lindsey
Journal:  Pharmacol Res       Date:  2018-10-28       Impact factor: 7.658

2.  Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.

Authors:  Vasundhara Kain; Kevin A Ingle; Romain A Colas; Jesmond Dalli; Sumanth D Prabhu; Charles N Serhan; Medha Joshi; Ganesh V Halade
Journal:  J Mol Cell Cardiol       Date:  2015-04-11       Impact factor: 5.000

3.  Immune responsive resolvin D1 programs peritoneal macrophages and cardiac fibroblast phenotypes in diversified metabolic microenvironment.

Authors:  Vasundhara Kain; Ganesh V Halade
Journal:  J Cell Physiol       Date:  2018-09-07       Impact factor: 6.384

Review 4.  Obesity and Cardiometabolic Defects in Heart Failure Pathology.

Authors:  Ganesh V Halade; Vasundhara Kain
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

5.  Splenic leukocytes define the resolution of inflammation in heart failure.

Authors:  Ganesh V Halade; Paul C Norris; Vasundhara Kain; Charles N Serhan; Kevin A Ingle
Journal:  Sci Signal       Date:  2018-03-06       Impact factor: 8.192

Review 6.  Re-evaluating the causes and consequences of non-resolving inflammation in chronic cardiovascular disease.

Authors:  Amanda B Pullen; Jeevan Kumar Jadapalli; Boutayna Rhourri-Frih; Ganesh V Halade
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

7.  Cardiomyocyte-specific Bmal1 deletion in mice triggers diastolic dysfunction, extracellular matrix response, and impaired resolution of inflammation.

Authors:  Kevin A Ingle; Vasundhara Kain; Mehak Goel; Sumanth D Prabhu; Martin E Young; Ganesh V Halade
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-02       Impact factor: 4.733

8.  A novel path of improving heart function after infarction.

Authors:  Kirkwood A Pritchard; Dorothee Weihrauch
Journal:  J Mol Cell Cardiol       Date:  2015-05-02       Impact factor: 5.000

9.  Subacute treatment of carprofen facilitate splenocardiac resolution deficit in cardiac injury.

Authors:  Ganesh V Halade; Vasundhara Kain; Griffin M Wright; Jeevan Kumar Jadapalli
Journal:  J Leukoc Biol       Date:  2018-08-26       Impact factor: 4.962

10.  Immune responsive resolvin D1 programs myocardial infarction-induced cardiorenal syndrome in heart failure.

Authors:  Ganesh V Halade; Vasundhara Kain; Charles N Serhan
Journal:  FASEB J       Date:  2018-02-13       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.